SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 398 filers reported holding SEATTLE GENETICS INC in Q4 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,993,000 | -18.8% | 23,500 | -44.8% | 0.06% | -30.6% |
| Q1 2020 | $4,915,000 | +42.9% | 42,600 | +41.5% | 0.08% | +77.1% |
| Q4 2019 | $3,439,000 | +316.8% | 30,100 | +98.4% | 0.05% | +700.0% |
| Q4 2017 | $825,000 | 0.0% | 15,171 | 0.0% | 0.01% | -53.8% |
| Q3 2017 | $825,000 | -13.3% | 15,171 | -17.5% | 0.01% | -18.8% |
| Q2 2017 | $952,000 | -16.8% | 18,400 | +1.1% | 0.02% | -27.3% |
| Q1 2017 | $1,144,000 | +19.2% | 18,200 | 0.0% | 0.02% | +10.0% |
| Q4 2016 | $960,000 | – | 18,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |